Process View
The orderly movement of a muscle cell from one site to another, often during the development of a multicellular organism.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "muscle cell migration"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| EGFR | epidermal growth factor receptor | 1.000 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.999 | ||
| VEGFA | vascular endothelial growth factor A | 0.998 | Human | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.993 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.984 | Human | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.978 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.977 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.970 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.962 | ||
| PLAU | plasminogen activator, urokinase | 0.960 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.932 | ||
| ILK | integrin-linked kinase | 0.926 | Rat | |
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.916 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.903 | Mouse | |
| FN1 | fibronectin 1 | 0.842 | ||
| NRP1 | neuropilin 1 | 0.819 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.783 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.774 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.759 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.755 | ||
| GGA2 | golgi-associated, gamma adaptin ear containing, ARF binding protein 2 | 0.753 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.747 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.729 | Human | |
| IGF1R | insulin-like growth factor 1 receptor | 0.715 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.697 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.676 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.594 | ||
| PXN | paxillin | 0.516 | ||
| PLAT | plasminogen activator, tissue | 0.466 | Human Mouse | |
| THBS1 | thrombospondin 1 | 0.460 | Human | |
| GAB1 | GRB2-associated binding protein 1 | 0.450 | ||
| IL1B | interleukin 1, beta | 0.365 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.364 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.339 | Human | |
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.320 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.320 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.286 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.277 | Human | |
| LAT | linker for activation of T cells | 0.271 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.239 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.234 | ||
| RABEP1 | rabaptin, RAB GTPase binding effector protein 1 | 0.233 | ||
| IDE | insulin-degrading enzyme | 0.228 | ||
| IL8 | interleukin 8 | 0.219 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.212 | ||
| PGF | placental growth factor | 0.188 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.182 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.182 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.175 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.162 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.160 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.160 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.150 | Human | |
| PDGFC | platelet derived growth factor C | 0.150 | ||
| SORT1 | sortilin 1 | 0.149 | Human | |
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.136 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.133 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.130 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.129 | Human | |
| DCN | decorin | 0.127 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.126 | ||
| GGA1 | golgi-associated, gamma adaptin ear containing, ARF binding protein 1 | 0.124 | ||
| JAK2 | Janus kinase 2 | 0.123 | ||
| INO80B | INO80 complex subunit B | 0.122 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.109 | ||
| TLN1 | talin 1 | 0.104 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.102 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.100 | ||
| IRS1 | insulin receptor substrate 1 | 0.092 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.091 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.091 | ||
| AXL | AXL receptor tyrosine kinase | 0.086 | ||
| ESRRG | estrogen-related receptor gamma | 0.086 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.084 | ||
| PARVA | parvin, alpha | 0.084 | Mouse | |
| INSR | insulin receptor | 0.081 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.080 | Human | |
| HSPG2 | heparan sulfate proteoglycan 2 | 0.080 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.079 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.073 | ||
| ATF5 | activating transcription factor 5 | 0.073 | ||
| INHBA | inhibin, beta A | 0.072 | ||
| NCK2 | NCK adaptor protein 2 | 0.069 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.068 | ||
| SYNRG | synergin, gamma | 0.067 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.067 | ||
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.064 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.061 | Human | |
| OSMR | oncostatin M receptor | 0.058 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.055 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.055 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.053 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.053 | ||
| VEGFC | vascular endothelial growth factor C | 0.052 | Human | |
| ADAM12 | ADAM metallopeptidase domain 12 | 0.051 | ||
| STC1 | stanniocalcin 1 | 0.051 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.050 | Human | |
| CD163 | CD163 molecule | 0.050 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.049 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.049 | ||
| ENG | endoglin | 0.048 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.048 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.048 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.048 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.047 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.047 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.046 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.045 | ||
| THBS2 | thrombospondin 2 | 0.045 | Human | |
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.044 | ||
| STAB1 | stabilin 1 | 0.044 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.043 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.043 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.043 | Rat | |
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.041 | Human | |
| NNMT | nicotinamide N-methyltransferase | 0.041 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.040 | Human | |
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.039 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.037 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.037 | ||
| S100B | S100 calcium binding protein B | 0.037 | ||
| TF | transferrin | 0.036 | ||
| RHOA | ras homolog gene family, member A | 0.036 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.036 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.036 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.036 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.036 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.036 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.035 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.035 | ||
| GHR | growth hormone receptor | 0.034 | ||
| MEF2A | myocyte enhancer factor 2A | 0.033 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.033 | ||
| NOV | nephroblastoma overexpressed gene | 0.032 | ||
| SORL1 | sortilin-related receptor, L(DLR class) A repeats containing | 0.031 | ||
| EEA1 | early endosome antigen 1 | 0.030 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.030 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.030 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.029 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.029 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.029 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.028 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.028 | Human | |
| CCL7 | chemokine (C-C motif) ligand 7 | 0.026 | Human | |
| SPRR2A | small proline-rich protein 2A | 0.026 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.026 | ||
| FHL2 | four and a half LIM domains 2 | 0.026 | ||
| THY1 | Thy-1 cell surface antigen | 0.025 | ||
| HAS2 | hyaluronan synthase 2 | 0.024 | Rat | |
| COL11A2 | collagen, type XI, alpha 2 | 0.024 | ||
| RANBP9 | RAN binding protein 9 | 0.024 | ||
| KITLG | KIT ligand | 0.023 | ||
| SPG21 | spastic paraplegia 21 (autosomal recessive, Mast syndrome) | 0.023 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.023 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.023 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.023 | ||
| LAMA4 | laminin, alpha 4 | 0.023 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.023 | Mouse | |
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.022 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.022 | ||
| NRP2 | neuropilin 2 | 0.022 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.022 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.022 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.022 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.021 | ||
| TTR | transthyretin | 0.020 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.020 | Human | |
| BTF3 | basic transcription factor 3 | 0.020 | ||
| PRRX1 | paired related homeobox 1 | 0.020 | ||
| FUNDC2 | FUN14 domain containing 2 | 0.020 | ||
| MMP19 | matrix metallopeptidase 19 | 0.020 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.019 | ||
| DOCK1 | dedicator of cytokinesis 1 | 0.019 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.019 | ||
| OLFML3 | olfactomedin-like 3 | 0.019 | ||
| FMOD | fibromodulin | 0.019 | ||
| MAPT | microtubule-associated protein tau | 0.019 | ||
| CUEDC2 | CUE domain containing 2 | 0.019 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.019 | ||
| IGFBP4 | insulin-like growth factor binding protein 4 | 0.019 | Human | |
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.018 | ||
| MARCO | macrophage receptor with collagenous structure | 0.018 | ||
| LDLR | low density lipoprotein receptor | 0.018 | ||
| SELE | selectin E | 0.018 | ||
| APP | amyloid beta (A4) precursor protein | 0.018 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.017 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.017 | ||
| SLAMF8 | SLAM family member 8 | 0.017 | ||
| PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 0.017 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.017 | ||
| TNC | tenascin C | 0.017 | ||
| CMIP | c-Maf-inducing protein | 0.017 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.017 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.017 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.017 | Human | |
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.016 | ||
| JAK1 | Janus kinase 1 | 0.016 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.016 | ||
| FLNA | filamin A, alpha | 0.016 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.016 | ||
| OCRL | oculocerebrorenal syndrome of Lowe | 0.016 | ||
| ITGB5 | integrin, beta 5 | 0.016 | ||
| CH25H | cholesterol 25-hydroxylase | 0.016 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.016 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.016 | ||
| LOX | lysyl oxidase | 0.015 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.015 | ||
| FST | follistatin | 0.015 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.015 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.014 | Human | |
| TFPI2 | tissue factor pathway inhibitor 2 | 0.014 | ||
| ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 0.014 | ||
| DPT | dermatopontin | 0.014 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.014 | ||
| IL10 | interleukin 10 | 0.014 | ||
| DARC | Duffy blood group, chemokine receptor | 0.014 | ||
| ARHGAP1 | Rho GTPase activating protein 1 | 0.014 | ||
| BMP1 | bone morphogenetic protein 1 | 0.014 | ||
| PAFAH1B3 | platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) | 0.013 | ||
| C2 | complement component 2 | 0.013 | ||
| COL14A1 | collagen, type XIV, alpha 1 | 0.013 | ||
| COASY | CoA synthase | 0.013 | ||
| MEF2C | myocyte enhancer factor 2C | 0.013 | ||
| PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.013 | ||
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.013 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.013 | ||
| PARVB | parvin, beta | 0.013 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.012 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.012 | ||
| GAS6 | growth arrest-specific 6 | 0.012 | ||
| ECM1 | extracellular matrix protein 1 | 0.012 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.012 | ||
| IL4R | interleukin 4 receptor | 0.012 | ||
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.012 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.012 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.012 | ||
| IL7R | interleukin 7 receptor | 0.012 | ||
| AKAP2 | A kinase (PRKA) anchor protein 2 | 0.012 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.011 | ||
| FRZB | frizzled-related protein | 0.011 | ||
| TNF | tumor necrosis factor | 0.011 | ||
| FAP | fibroblast activation protein, alpha | 0.011 | ||
| COLEC12 | collectin sub-family member 12 | 0.011 | ||
| CD248 | CD248 molecule, endosialin | 0.011 | ||
| PTHLH | parathyroid hormone-like hormone | 0.011 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.011 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.011 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.011 | ||
| ITGA6 | integrin, alpha 6 | 0.011 | ||
| ESR1 | estrogen receptor 1 | 0.011 | ||
| DLC1 | deleted in liver cancer 1 | 0.010 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.010 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.010 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.010 | ||
| LPAR1 | lysophosphatidic acid receptor 1 | 0.010 | Rat | |
| A2M | alpha-2-macroglobulin | 0.010 |